Keenova Targets Dupuytren's Contracture Awareness with 'Don't Be a Viking' Campaign

Event summary

  • Keenova launched a nationwide consumer campaign 'Don't Be a Viking' for Dupuytren's contracture awareness on May 4, 2026.
  • The campaign includes TV spots on major networks and streaming platforms, plus digital and social media components.
  • The initiative aims to address treatment delays among the estimated 13 million Americans affected by the condition.
  • Keenova's consumer research shows many patients adapt to symptoms rather than seeking nonsurgical treatments.

The big picture

Keenova's campaign targets a significant unmet need in Dupuytren's contracture management, where patients often delay treatment due to fear of surgery. The initiative aligns with broader industry trends toward patient education and nonsurgical interventions for chronic conditions. With a strong U.S. manufacturing footprint and diversified portfolio, Keenova is positioning itself as a leader in rare disease therapeutics.

What we're watching

Campaign Effectiveness
Whether the 'Don't Be a Viking' campaign can significantly reduce treatment delays among Dupuytren's contracture patients.
Market Penetration
The pace at which Keenova can expand awareness and specialist referrals through FindaHandSpecialist.com.
Competitive Positioning
How this initiative positions Keenova against competitors in the rare disease therapeutics space.